Immunotherapy with an HIV-DNA Vaccine in Children and Adults

Author： Palma Paolo Gudmundsdotter Lindvi Finocchi Andrea Eriksson Lars E. Mora Nadia Santilli Veronica Aquilani Angela Manno Emma C. Zangari Paola Romiti Maria Luisa Montesano Carla Grifoni Alba Brave Andreas Ljungberg Karl Blomberg Pontus Bernardi Stefania Sandström Eric Hejdeman Bo Rossi Paolo Wahren Britta

Publisher： MDPI

E-ISSN： 2076-393x|2|3|563-580

ISSN： 2076-393x

Source： Vaccines, Vol.2, Iss.3, 2014-07, pp. : 563-580

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA Immunization for HIV Vaccine Development

By Chen Yuxin Wang Shixia Lu Shan

Vaccines, Vol. 2, Iss. 1, 2014-02 ,pp. : 138-159

MDPI

Access to resources Recommend Favorite

HIV DNA Vaccine: Stepwise Improvements Make a Difference

By Felber Barbara K. Valentin Antonio Rosati Margherita Bergamaschi Cristina Pavlakis George N.

Vaccines, Vol. 2, Iss. 2, 2014-05 ,pp. : 354-379

MDPI

Access to resources Recommend Favorite

Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling

By Yan Jiabin Zapata Juan Carlos Pauza Charles David Salvato Maria S.

Viruses, Vol. 7, Iss. 3, 2015-03 ,pp. : 1429-1453

MDPI

Access to resources Recommend Favorite

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults

By Montomoli Emanuele Torelli Alessandro Manini Ilaria Gianchecchi Elena

Vaccines, Vol. 6, Iss. 1, 2018-03 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity

By Ajamian Lara Melnychuk Luca Jean-Pierre Patrick Zaharatos Gerasimos J.

Viruses, Vol. 10, Iss. 3, 2018-02 ,pp. : 100-100

MDPI

Access to resources Recommend Favorite